CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to CLVS

Trastuzumab and Pertuzumab (combination treatment)

Phase 2
Clovis Oncology, Inc. (CLVS)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Sep '27
CLVSPhase 2

Trastuzumab and Pertuzumab (combination treatment) Phase 2 Est. Readout (DRUP)

Trastuzumab and Pertuzumab (combination treatment)
Sep 2027~
CT.gov
00%
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.